Evidence map›Paper›PMID 24005336›Full record

ArticleNeurology2013

Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers.

Claudia Jacova, Ging-Yuek R Hsiung, Itthipol Tawankanjanachot, Katie Dinelle, Siobhan McCormick, Marjorie Gonzalez, Hyunsoo Lee, Pheth Sengdy, Phoenix Bouchard-Kerr, Matthew Baker and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 3 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 3 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Frontotemporal Dementia and Glucose Metabolism.Frontiers in neuroscience · 2022
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Claudia JacovaFrom the Division of Neurology, Department of Medicine (C.J., G.-Y.R.H., I.T., H.L., P.S., P.B.-K., A.J.S., H.H.F.), Department of Physics and Astronomy (K.D., S.M., M.G., V.S.), and Department of Pathology and Laboratory Medicine (I.R.M.), University of British Columbia, Vancouver, Canada; and Department of Neuroscience (M.B., R.R.), Mayo Clinic, Jacksonville, FL.
Ging-Yuek R Hsiung
Itthipol Tawankanjanachot
Katie Dinelle
Siobhan McCormick
Marjorie Gonzalez
Hyunsoo Lee
Pheth Sengdy
Phoenix Bouchard-Kerr
Matthew Baker
Rosa Rademakers
Vesna Sossi
A Jon Stoessl
Howard H Feldman
Ian R Mackenzie
Jacksonville College · US

Funding

Progranulin: Mutation and Regulation in Neurodegenerative diseaseR01NS065782 · NINDS · MAYO CLINIC JACKSONVILLE · PI RADEMAKERS, ROSA · 2009 to 2012
$1.3M
Canadian Institutes of Health Research 179009Canadian Institutes of Health Research 74580NINDS NIH HHS R01 NS065782
6 · The paper itself

Abstract

objectiveIn this prospective cohort study, we investigated cerebral glucose metabolism reductions on [(18)F]-fluorodeoxyglucose (FDG)-PET in progranulin (GRN) mutation carriers prior to frontotemporal dementia (FTD) onset.

methodsNine mutation carriers (age 51.5 ± 13.5 years) and 11 noncarriers (age 52.7 ± 9.5 years) from 5 families with FTD due to GRN mutations underwent brain scanning with FDG-PET and MRI and clinical evaluation. Normalized FDG uptake values were calculated with reference to the pons. PET images were analyzed with regions of interest (ROI) and statistical parametric mapping (SPM) approaches.

resultsCompared with noncarriers, GRN mutation carriers had a lowered anterior-to-posterior (AP) ratio of FDG uptake (0.86 ± 0.09 vs 0.92 ± 0.05) and less left-right asymmetry, consistent with an overall pattern of right anterior cerebral hypometabolism. This pattern was observed regardless of whether they were deemed clinically symptomatic no dementia or asymptomatic. Individual ROIs with lowered FDG uptake included right anterior cingulate, insula, and gyrus rectus. SPM analysis supported and extended these findings, demonstrating abnormalities in the right and left medial frontal regions, right insular cortex, right precentral and middle frontal gyri, and right cerebellum. Right AP ratio was correlated with cognitive and clinical scores (modified Mini-Mental State Examination r = 0.74; Functional Rating Scale r = -0.73) but not age and years to estimated onset in mutation carriers.

conclusionThe frontotemporal lobar degenerative process associated with GRN mutations appears to begin many years prior to the average age at FTD onset (late 50s-early 60s). Right medial and ventral frontal cortex and insula may be affected in this process but the specific regional patterns associated with specific clinical variants remain to be elucidated.

Indexed as

DementiaAdultAgedBrain MappingDisease ProgressionFemaleFluorodeoxyglucose F18Frontal LobeGlucoseHumansIntercellular Signaling Peptides and ProteinsMagnetic Resonance ImagingMaleMiddle AgedMutationPositron-Emission TomographyFluorodeoxyglucose F18GlucoseGRN protein, humanIntercellular Signaling Peptides and ProteinsProgranulins

Identifiers

PMID24005336
PMCPMC3806924
OpenAlexW2102843554

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.